Joan Genescà Ferrer-rekin lankidetzan egindako argitalpenak (8)

2008

  1. Response to Heish et al. [6]

    American Journal of Gastroenterology

2007

  1. Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C

    American Journal of Gastroenterology, Vol. 102, Núm. 10, pp. 2189-2195

2006

  1. Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis

    Diabetes Care, Vol. 29, Núm. 5, pp. 1140-1149

  2. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study

    Diabetes Care, Vol. 29, Núm. 5, pp. 1096-1101

  3. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection

    Diabetes Care, Vol. 29, Núm. 11, pp. 2462-2466

2005

  1. Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection: Response to Lecube et al.

    Diabetes Care

2004

  1. Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection

    Diabetes Care, Vol. 27, Núm. 11, pp. 2669-2675

  2. High Prevalence of Glucose Abnormalities in Patients with Hepatitis C Virus Infection: A multivariate analysis considering the liver injury

    Diabetes Care, Vol. 27, Núm. 5, pp. 1171-1175